Fundraising Fox

Edward Dulac

Executive Vice President, Chief Financial Officer at Intellia Therapeutics

San Diego, California, United States

Find your path to Edward

527 people in our graph share verified history with Edward — schools, employers, funds. One of them is your warm intro.

Bertie AykroydunlockedEdward: together at Barclays (2007–2010)
×6Edward: together at Barclays
×2Edward: together at HKUST Business School
Edward: together at Intellia Therapeutics

Executive Vice President, Chief Financial Officer at Intellia Therapeutics

Intro paths

→

In turn, Edward can intro founders to Intellia Therapeutics's investors below.

Intellia Therapeutics's investors · 7

age1San Francisco · $500K – $4M checks · since 2015Atlas VentureCambridge · $500K – $1M checks · since 2015Avoro Capital AdvisorsNew York · since 2015EcoR1 CapitalSan Francisco · since 2015Fidelity InvestmentsBostonForesite CapitalWest Hollywood · since 2015OrbiMedNew York · $1M – $75M checks

Co-founders at Intellia Therapeutics

NBNessan Bermingham
Nessan BerminghamExecutive Officer, Director
JD
Jennifer DoudnaCo-founder

Experience

  1. Intellia Therapeutics, Inc.Chief Financial Officercurrent2024 — presentSan Diego, California, United States
  2. Fate Therapeutics IncChief Financial Officer2020 — 2024San Diego, California, United States
  3. CelgeneVice President, Business Development & Strategy2017 — 2020Greater New York City Area
  4. CelgeneHead of Portfolio Analysis & Strategy, Hematology & Oncology2016 — 2017Greater New York City Area
  5. CelgeneSenior Director, Business Development; Hematology & Oncology2015 — 2016Summit, NJ
  6. CelgeneDirector, Global Marketing2012 — 2015Summit, NJ
  7. Obsidian TherapeuticsBoard Observer2019 — 2020Greater Boston Area
  8. Nohla TherapeuticsBoard Observer2018 — 2020Greater Seattle Area
  9. Barclays CapitalVice President; Pharmaceuticals Equity Analyst2009 — 2012London, United Kingdom
  10. Barclays CapitalAssistant Vice President; Equity Research - U.S. Major Pharmaceuticals2007 — 2009Greater New York City Area
  11. PfizerCorporate Finance Manager2003 — 2007Greater New York City Area

Skills & more

Competitive Analysis17Financial Modeling13Leadership9Equities5Competitive Intelligence4Market Access4Financial Analysis4Cross-functional Team Leadership3Investments3Market Analysis3Analysis3Global Marketing3
+8 moreCommercializationPortfolio ManagementAnalyticsEmerging MarketsPricingCorporate FinanceBusiness DevelopmentMergers & Acquisitions
  • Registered Pharmacist — NCBOP
  • FINRA Series 7, Series 63, Series 86, Series 87 — FINRA

From Edward's professional profile.

Frequently asked questions

Who is Edward Dulac?
Executive Vice President, Chief Financial Officer at Intellia Therapeutics
Where does Edward Dulac work?
Edward Dulac is Executive Vice President, Chief Financial Officer at Intellia Therapeutics.
Where did Edward Dulac go to school?
Edward Dulac studied at Indiana University - Kelley School of Business (Master of Business Administration - MBA, Finance, Marketing, International Business); HKUST Business School (Master of Business Administration - MBA, Finance (study abroad)); University of Pittsburgh (Bachelor's of Pharmacy).

Same school

Also attended Indiana University - Kelley School of Business206

Scott D. DorseyInvestor at High AlphaJoe HaraVice President at Marlin Equity PartnersJack AleksanyanDirector at Marlin Equity PartnersDoug SillsPartner at Anthem Venture Management, LlcDanisha PasayaAnalyst, M&A Advisory at eGateway CapitalAaron DonenbergPortfolio Finance Associate at Energize Ventures

+ 200 more

Also attended HKUST Business School53

Raoul Oscar FianoInvestor at DN CapitalRavi RajamonyVice President at March Capital PartnersPavel TinkovGeneral Partner & Founder at AUDEO VENTURESCatherine Ouellet-DupuisGeneral Partner at White Star CapitalAndreas HadjitofiAssociate at Quadri VenturesCarey LaiCo-Founder & General Partner at Conductive Ventures

+ 47 more

Also attended University of Pittsburgh144

Yervand SarkisyanInvestor in deep tech and AIJon KaplanExecutive Venture Partner at Caduceus Capital PartnersSalvador GalaCo-founder & Managing Partner at Ev3 Ventures LlcJustin MaresBuilding companies at the intersection of health and technology.Kelly BarnumDirector Of Talent at Volition CapitalMatt GurinDirector, Finance and Operations at RRE Ventures

+ 138 more

Shared employers

Also worked at Intellia Therapeutics, Inc.9

Nessan BerminghamInvestor at Khosla VenturesJennifer SmoterChief Communications & Governance Officer at Takeda VenturesRodolphe BarrangouCo-founder at Ancilia BioBrian GoffChief Executive Officer at Agios PharmaceuticalsJose RiveraExecutive Officer at Intellia TherapeuticsJohn LeonardPresident and Chief Executive Officer at Intellia Therapeutics

+ 3 more

Also worked at Fate Therapeutics Inc6

Amir NashatEntrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive rolesJill MooneyAdvisor at Avalon BioVenturesAndreas NiethammerFounder & Chief Executive Officer at VaximmPratik MultaniChief Medical Officer at ORIC PharmaceuticalsZachary D. HornbyExecutive Officer, Director at Boundless BioBahram (Bob) ValamehrPresident & Chief Executive Officer at Fate Therapeutics

Also worked at Obsidian Therapeutics1

Maria FardisVenture Partner at Frazier Life Sciences

Also worked at Nohla Therapeutics1

Sarah NoonbergChief Medical Officer at AbCellera